POON CHRISTINE A sold REGN

November 2, 2026 · Form 4 insider transaction

POON CHRISTINE A sold 2,499 shares of Regeneron Pharmaceuticals, Inc. at $968.58 per share, a transaction worth $2.42M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
2,499
Price
$968.58
Total value
$2.42M
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 2, 2026
Filing dateNovember 4, 2026
Shares owned after9,560
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents volume-weighted average price of sales of 2,499 shares of Company stock on November 2, 2026 at prices ranging from $968.00 to $968.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

View the original Form 4 on SEC EDGAR
POON CHRISTINE A sold REGN: November 2, 2026 | Insider Trading Screener